nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—AGTR1—abdominal aortic aneurysm	0.911	1	CbGaD
Irbesartan—JUN—artery—abdominal aortic aneurysm	0.00351	0.156	CbGeAlD
Irbesartan—Forasartan—AGTR1—abdominal aortic aneurysm	0.00321	0.303	CrCbGaD
Irbesartan—AGTR1—artery—abdominal aortic aneurysm	0.00264	0.118	CbGeAlD
Irbesartan—AGTR1—blood plasma—abdominal aortic aneurysm	0.00198	0.0884	CbGeAlD
Irbesartan—Tasosartan—AGTR1—abdominal aortic aneurysm	0.00194	0.184	CrCbGaD
Irbesartan—Valsartan—AGTR1—abdominal aortic aneurysm	0.00168	0.159	CrCbGaD
Irbesartan—Olmesartan—AGTR1—abdominal aortic aneurysm	0.00164	0.155	CrCbGaD
Irbesartan—JUN—connective tissue—abdominal aortic aneurysm	0.0014	0.0625	CbGeAlD
Irbesartan—Candesartan—AGTR1—abdominal aortic aneurysm	0.00128	0.121	CrCbGaD
Irbesartan—JUN—kidney—abdominal aortic aneurysm	0.00119	0.0532	CbGeAlD
Irbesartan—PTGS1—artery—abdominal aortic aneurysm	0.00116	0.0518	CbGeAlD
Irbesartan—CYP2C8—blood plasma—abdominal aortic aneurysm	0.00107	0.0479	CbGeAlD
Irbesartan—AGTR1—connective tissue—abdominal aortic aneurysm	0.00106	0.047	CbGeAlD
Irbesartan—CYP1A2—blood plasma—abdominal aortic aneurysm	0.00101	0.0448	CbGeAlD
Irbesartan—CYP2C9—blood plasma—abdominal aortic aneurysm	0.000954	0.0425	CbGeAlD
Irbesartan—JUN—spinal cord—abdominal aortic aneurysm	0.000929	0.0414	CbGeAlD
Irbesartan—AGTR1—kidney—abdominal aortic aneurysm	0.000898	0.04	CbGeAlD
Irbesartan—PTGS1—blood plasma—abdominal aortic aneurysm	0.000871	0.0388	CbGeAlD
Irbesartan—Losartan—AGTR1—abdominal aortic aneurysm	0.000822	0.0778	CrCbGaD
Irbesartan—CYP3A4—blood plasma—abdominal aortic aneurysm	0.000728	0.0324	CbGeAlD
Irbesartan—CYP2D6—blood plasma—abdominal aortic aneurysm	0.000716	0.0319	CbGeAlD
Irbesartan—JUN—Estrogen signaling pathway—NFKB1—abdominal aortic aneurysm	0.00056	0.01	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.000553	0.00989	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—LDLR—abdominal aortic aneurysm	0.000552	0.00987	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.000542	0.00968	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—abdominal aortic aneurysm	0.000541	0.00967	CbGpPWpGaD
Irbesartan—JUN—Calcium signaling in the CD4+ TCR pathway—PTGS2—abdominal aortic aneurysm	0.000536	0.00958	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—PTGS2—abdominal aortic aneurysm	0.000525	0.00938	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—LDLR—abdominal aortic aneurysm	0.000524	0.00936	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—abdominal aortic aneurysm	0.000515	0.0092	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000489	0.00874	CbGpPWpGaD
Irbesartan—CYP2C8—kidney—abdominal aortic aneurysm	0.000487	0.0217	CbGeAlD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000474	0.00847	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.000472	0.00843	CbGpPWpGaD
Irbesartan—PTGS1—connective tissue—abdominal aortic aneurysm	0.000464	0.0207	CbGeAlD
Irbesartan—JUN—Signaling mediated by p38-alpha and p38-beta—PTGS2—abdominal aortic aneurysm	0.000461	0.00824	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—MMP9—abdominal aortic aneurysm	0.000446	0.00797	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—NFKB1—abdominal aortic aneurysm	0.000441	0.00788	CbGpPWpGaD
Irbesartan—EDNRA—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.000436	0.00779	CbGpPWpGaD
Irbesartan—PTGS1—Eicosanoid Synthesis—PTGS2—abdominal aortic aneurysm	0.000435	0.00778	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.000434	0.00776	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000434	0.00775	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.00043	0.00769	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—NOS2—abdominal aortic aneurysm	0.000413	0.00738	CbGpPWpGaD
Irbesartan—JUN—IL1-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.00041	0.00732	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.000403	0.0072	CbGpPWpGaD
Irbesartan—PTGS1—kidney—abdominal aortic aneurysm	0.000395	0.0176	CbGeAlD
Irbesartan—JUN—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.000394	0.00705	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—CCL2—abdominal aortic aneurysm	0.000394	0.00704	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.000392	0.00701	CbGpPWpGaD
Irbesartan—JUN—CD40/CD40L signaling—NFKB1—abdominal aortic aneurysm	0.000391	0.00699	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.00039	0.00696	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—abdominal aortic aneurysm	0.000387	0.00692	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.000378	0.00675	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.000378	0.00675	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—SERPINE1—abdominal aortic aneurysm	0.000373	0.00667	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000372	0.00665	CbGpPWpGaD
Irbesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.000364	0.00651	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000361	0.00645	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—MMP2—abdominal aortic aneurysm	0.000354	0.00633	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—MMP9—abdominal aortic aneurysm	0.00035	0.00625	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000347	0.00621	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—abdominal aortic aneurysm	0.000347	0.0062	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000346	0.00618	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.000337	0.00602	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—MMP2—abdominal aortic aneurysm	0.000332	0.00593	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—SOD2—abdominal aortic aneurysm	0.000331	0.00591	CbGpPWpGaD
Irbesartan—CYP3A4—kidney—abdominal aortic aneurysm	0.00033	0.0147	CbGeAlD
Irbesartan—JUN—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.000325	0.00581	CbGpPWpGaD
Irbesartan—CYP2D6—kidney—abdominal aortic aneurysm	0.000325	0.0145	CbGeAlD
Irbesartan—JUN—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.000324	0.00579	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000318	0.00568	CbGpPWpGaD
Irbesartan—JUN—Selenium Metabolism and Selenoproteins—NFKB1—abdominal aortic aneurysm	0.000316	0.00565	CbGpPWpGaD
Irbesartan—PTGS1—spinal cord—abdominal aortic aneurysm	0.000308	0.0137	CbGeAlD
Irbesartan—EDNRA—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000307	0.00548	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.000303	0.00541	CbGpPWpGaD
Irbesartan—JUN—Regulation of retinoblastoma protein—CDKN2A—abdominal aortic aneurysm	0.000297	0.00531	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.00029	0.00518	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000289	0.00516	CbGpPWpGaD
Irbesartan—JUN—FGF signaling pathway—MMP9—abdominal aortic aneurysm	0.000286	0.00511	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000283	0.00506	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000283	0.00506	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—NFKB1—abdominal aortic aneurysm	0.000283	0.00506	CbGpPWpGaD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000279	0.00498	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—NFKB1—abdominal aortic aneurysm	0.000279	0.00498	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—abdominal aortic aneurysm	0.000278	0.00496	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000274	0.0049	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000274	0.0049	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000273	0.00487	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—SERPINE1—abdominal aortic aneurysm	0.00027	0.00482	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—CCL2—abdominal aortic aneurysm	0.000261	0.00467	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—NFKB1—abdominal aortic aneurysm	0.000257	0.00459	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—abdominal aortic aneurysm	0.000255	0.00455	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—MMP9—abdominal aortic aneurysm	0.00025	0.00446	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.000249	0.00446	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—NFKB1—abdominal aortic aneurysm	0.000247	0.00441	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.000245	0.00438	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.000245	0.00438	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.000244	0.00435	CbGpPWpGaD
Irbesartan—PTGS1—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000242	0.00432	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.000241	0.00431	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000241	0.0043	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—NFKB1—abdominal aortic aneurysm	0.000238	0.00425	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.000238	0.00425	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—NFKB1—abdominal aortic aneurysm	0.000235	0.0042	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—MMP9—abdominal aortic aneurysm	0.000232	0.00415	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—CDKN2A—abdominal aortic aneurysm	0.00023	0.0041	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00022	0.00393	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—SERPINE1—abdominal aortic aneurysm	0.000219	0.00392	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—abdominal aortic aneurysm	0.000218	0.00389	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000215	0.00385	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—abdominal aortic aneurysm	0.000209	0.00373	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—abdominal aortic aneurysm	0.000205	0.00366	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—CDKN2A—abdominal aortic aneurysm	0.000205	0.00366	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000204	0.00365	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000203	0.00363	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—NFKB1—abdominal aortic aneurysm	0.000203	0.00362	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—CDKN2A—abdominal aortic aneurysm	0.000199	0.00355	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—NFKB1—abdominal aortic aneurysm	0.000199	0.00355	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—NFKB1—abdominal aortic aneurysm	0.000197	0.00352	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.000196	0.0035	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—abdominal aortic aneurysm	0.000195	0.00348	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—NFKB1—abdominal aortic aneurysm	0.000191	0.00342	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000189	0.00338	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000188	0.00336	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—NFKB1—abdominal aortic aneurysm	0.000186	0.00333	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000185	0.00331	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—CDKN2A—abdominal aortic aneurysm	0.000185	0.00331	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000185	0.0033	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—abdominal aortic aneurysm	0.000185	0.0033	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—NFKB1—abdominal aortic aneurysm	0.000182	0.00325	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—MMP2—abdominal aortic aneurysm	0.000178	0.00317	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000177	0.00316	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000176	0.00315	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—SERPINE1—abdominal aortic aneurysm	0.000174	0.00311	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—NFKB1—abdominal aortic aneurysm	0.000174	0.00311	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.000172	0.00308	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00017	0.00304	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000167	0.00299	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—abdominal aortic aneurysm	0.000166	0.00297	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—SOD2—abdominal aortic aneurysm	0.000163	0.00291	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—NFKB1—abdominal aortic aneurysm	0.000161	0.00288	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00016	0.00286	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000159	0.00285	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—NFKB1—abdominal aortic aneurysm	0.000157	0.0028	CbGpPWpGaD
Irbesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000156	0.00279	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—NOS2—abdominal aortic aneurysm	0.000155	0.00277	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000155	0.00276	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000154	0.00275	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—abdominal aortic aneurysm	0.000147	0.00263	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.000146	0.00261	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000145	0.0026	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000134	0.00239	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—NFKB1—abdominal aortic aneurysm	0.000133	0.00237	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.000131	0.00235	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000131	0.00235	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—SERPINE1—abdominal aortic aneurysm	0.00013	0.00233	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN2A—abdominal aortic aneurysm	0.00013	0.00232	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.000129	0.00231	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000127	0.00228	CbGpPWpGaD
Irbesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000127	0.00227	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000124	0.00222	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000124	0.00222	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.000122	0.00217	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000121	0.00217	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.000121	0.00216	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000119	0.00212	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000117	0.00209	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.000116	0.00208	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000114	0.00204	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000113	0.00202	CbGpPWpGaD
Irbesartan—JUN—Immune System—SELL—abdominal aortic aneurysm	0.00011	0.00197	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000109	0.00196	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000109	0.00196	CbGpPWpGaD
Irbesartan—CYP1A2—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000109	0.00194	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—NFKB1—abdominal aortic aneurysm	0.000105	0.00188	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000103	0.00184	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.000101	0.0018	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.0001	0.0018	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	9.99e-05	0.00179	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN2A—abdominal aortic aneurysm	9.79e-05	0.00175	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	9.75e-05	0.00174	CbGpPWpGaD
Irbesartan—JUN—Immune System—AAAS—abdominal aortic aneurysm	9.21e-05	0.00165	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LRP1—abdominal aortic aneurysm	9.18e-05	0.00164	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LDLR—abdominal aortic aneurysm	8.87e-05	0.00159	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AAAS—abdominal aortic aneurysm	8.83e-05	0.00158	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AGT—abdominal aortic aneurysm	8.74e-05	0.00156	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	8.59e-05	0.00154	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NCF1—abdominal aortic aneurysm	8.3e-05	0.00148	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—NFKB1—abdominal aortic aneurysm	7.95e-05	0.00142	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AGT—abdominal aortic aneurysm	7.93e-05	0.00142	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	7.89e-05	0.00141	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—LDLR—abdominal aortic aneurysm	7.71e-05	0.00138	CbGpPWpGaD
Irbesartan—JUN—Immune System—NCF1—abdominal aortic aneurysm	7.52e-05	0.00134	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	6.96e-05	0.00124	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LRP1—abdominal aortic aneurysm	6.86e-05	0.00123	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	6.86e-05	0.00123	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.66e-05	0.00119	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL2—abdominal aortic aneurysm	6.53e-05	0.00117	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	6.51e-05	0.00116	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—P2RY12—abdominal aortic aneurysm	6.42e-05	0.00115	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	6.3e-05	0.00113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AGT—abdominal aortic aneurysm	6.23e-05	0.00111	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP3—abdominal aortic aneurysm	5.94e-05	0.00106	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LDLR—abdominal aortic aneurysm	5.2e-05	0.000929	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	5.15e-05	0.000921	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	5.13e-05	0.000916	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	5.12e-05	0.000916	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	5.05e-05	0.000902	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AAAS—abdominal aortic aneurysm	4.97e-05	0.000889	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NCF1—abdominal aortic aneurysm	4.86e-05	0.000869	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AGT—abdominal aortic aneurysm	4.69e-05	0.000838	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	4.66e-05	0.000833	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—abdominal aortic aneurysm	4.59e-05	0.000821	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	4.38e-05	0.000783	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—LDLR—abdominal aortic aneurysm	4.34e-05	0.000776	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NFKB1—abdominal aortic aneurysm	4.25e-05	0.00076	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AGT—abdominal aortic aneurysm	4.07e-05	0.000728	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—abdominal aortic aneurysm	3.99e-05	0.000713	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AGTR1—abdominal aortic aneurysm	3.9e-05	0.000698	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.86e-05	0.00069	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AGT—abdominal aortic aneurysm	3.68e-05	0.000657	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.6e-05	0.000644	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—abdominal aortic aneurysm	3.6e-05	0.000644	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP3—abdominal aortic aneurysm	3.48e-05	0.000622	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	3.46e-05	0.000618	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	3.33e-05	0.000595	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	3.26e-05	0.000583	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	3.21e-05	0.000574	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.03e-05	0.000541	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.83e-05	0.000505	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	2.8e-05	0.000501	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.76e-05	0.000493	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AGT—abdominal aortic aneurysm	2.75e-05	0.000491	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—abdominal aortic aneurysm	2.73e-05	0.000489	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.73e-05	0.000488	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	2.71e-05	0.000484	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—abdominal aortic aneurysm	2.69e-05	0.000481	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	2.65e-05	0.000474	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	2.64e-05	0.000471	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	2.61e-05	0.000467	CbGpPWpGaD
Irbesartan—JUN—Immune System—NFKB1—abdominal aortic aneurysm	2.48e-05	0.000443	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	2.31e-05	0.000414	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	2.3e-05	0.000411	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AGT—abdominal aortic aneurysm	2.29e-05	0.00041	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	2.28e-05	0.000408	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	2.27e-05	0.000405	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.26e-05	0.000404	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—abdominal aortic aneurysm	2.25e-05	0.000402	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	2.23e-05	0.000399	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	2.23e-05	0.000399	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.17e-05	0.000387	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.14e-05	0.000383	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.11e-05	0.000378	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	1.95e-05	0.000349	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.82e-05	0.000325	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	1.72e-05	0.000308	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.62e-05	0.000289	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.6e-05	0.000286	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.55e-05	0.000278	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—abdominal aortic aneurysm	1.54e-05	0.000275	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	1.5e-05	0.000269	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	1.48e-05	0.000265	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	1.45e-05	0.000259	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	1.22e-05	0.000217	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	1.21e-05	0.000216	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	1.19e-05	0.000213	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	1.18e-05	0.000211	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	1.03e-05	0.000184	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	1.01e-05	0.00018	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	9.95e-06	0.000178	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	8.17e-06	0.000146	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	8.1e-06	0.000145	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	7.95e-06	0.000142	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	7.79e-06	0.000139	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	6.92e-06	0.000124	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	5.34e-06	9.54e-05	CbGpPWpGaD
